| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/13/2008 | EP1251835B1 Closure of bacterial ghosts |
| 08/13/2008 | EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 08/13/2008 | EP1213028B1 Hm1.24 antigen expression potentiators |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP1133519B1 Functional antagonists of hedgehog activity |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | EP0936913B1 Oral pharmaceutical preparation containing ibandronat |
| 08/13/2008 | CN101243187A Method of producing lymphocytes |
| 08/13/2008 | CN101243092A Cripowellins and synthetic derivatives thereof used as medicaments |
| 08/13/2008 | CN101243084A Pyrrolo[2,3-B]pyridine derivatives as protein kinase inhibitors |
| 08/13/2008 | CN101243066A Delta and epsilon crystal forms of imatinib mesylate |
| 08/13/2008 | CN101243063A Sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents |
| 08/13/2008 | CN101243048A 1-acyldihydropyrazol derivatives |
| 08/13/2008 | CN101243043A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 08/13/2008 | CN101243039A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 08/13/2008 | CN101242847A Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators |
| 08/13/2008 | CN101242846A Synergistic modulation of FLT3 kinase using thienopyrimidine and thienopyridine kinase modulators |
| 08/13/2008 | CN101242845A Synergistic modulation of FLT3 kinase using a farnesyl transferase inhibitor |
| 08/13/2008 | CN101242844A Aminopyrimidines as kinase modulators |
| 08/13/2008 | CN101242843A Aminopyrimidines as kinase modulators |
| 08/13/2008 | CN101242842A Use of SANGLIFEHRIN in HCV |
| 08/13/2008 | CN101242841A Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 08/13/2008 | CN101242840A Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 08/13/2008 | CN101242838A Synergistic modulation of FLT3 kinase using aminoquinoline and aminoquinazoline kinase modulators |
| 08/13/2008 | CN101242837A Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators and a farnesyl transferase inhibitor |
| 08/13/2008 | CN101242817A Use of HIF1 alpha modulators for treatment of cancer |
| 08/13/2008 | CN101240275A Nucleic acid molecule SEPTIN1SR2 and application in producing immunity preparation |
| 08/13/2008 | CN101240274A Nucleic acid molecule SEPTIN1SR2 and application in preparing anti-leukemia medicament |
| 08/13/2008 | CN101240273A Nucleic acid molecule SEPTIN1SR1 and application in producing immunity preparation |
| 08/13/2008 | CN101240272A Nucleic acid molecule SEPTIN1SR1 and application in preparing anti-leukemia medicament |
| 08/13/2008 | CN101240022A Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 08/13/2008 | CN101240020A Breast cancer biological molecule marker LASS2 protein, modifying product and medical composition thereof |
| 08/13/2008 | CN101240007A Oleanane triterpene compound with containing multiple unsaturated double bonds and use thereof |
| 08/13/2008 | CN101240006A Oleanane triterpene compound with C ring containing conjugated double bond and use thereof |
| 08/13/2008 | CN101240005A Method for preparing platycodin D from balloon-flower root and application thereof in anti-cancer medicament |
| 08/13/2008 | CN101240002A Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239990A N-(2,3,4,5,6-pentahydroxyhexyl)-L-amino acid platinum ligand, preparation method and application thereof |
| 08/13/2008 | CN101239979A Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof |
| 08/13/2008 | CN101239978A Imidazopyridines compounds |
| 08/13/2008 | CN101239964A 15-oxospiramilactone and its medicament composition, preparation method and application |
| 08/13/2008 | CN101239959A Benzopyrone derivative, preparation method and medical use thereof |
| 08/13/2008 | CN101239936A Antineoplastic sulfur-containing alkannin and naphthoquinones derivatives |
| 08/13/2008 | CN101239929A Trichostatin A derivatives, preparation method and use thereof |
| 08/13/2008 | CN101239918A Beta-elemene diamine derivatives, synthesis method and use thereof |
| 08/13/2008 | CN101239915A Beta-elemene monosubstituted amine derivatives, synthetic method and use thereof |
| 08/13/2008 | CN101239190A Vitamin receptor binding drug delivery conjugates |
| 08/13/2008 | CN101239187A Functionalization carbon nano-tube for tumor lympha targeted therapeutic carrier |
| 08/13/2008 | CN101239183A Application of Septin1 protein in preparing medicaments for treating lymphocyte leukemia |
| 08/13/2008 | CN101239181A Histone demethylase related to cancer and uses thereof |
| 08/13/2008 | CN101239180A Complexes for target killing tumor cell, preparation and application thereof |
| 08/13/2008 | CN101239179A Non-aqueous polar aprotic peptide formulations |
| 08/13/2008 | CN101239161A Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma |
| 08/13/2008 | CN101239143A Chinese herbal medicine oral liquid formulations for treating oral tumor |
| 08/13/2008 | CN101239106A Pharmaceutical formulation with anticancer function |
| 08/13/2008 | CN101239101A Method for extracting low methoxyl pectin from ficus pumila perianth |
| 08/13/2008 | CN101239100A Application of Sichuan chinaberry extract in pharmaceutical and extracting method thereof |
| 08/13/2008 | CN101239094A Active component composition used as adjuvant drug for antitumor and preparation and application thereof |
| 08/13/2008 | CN101239093A Active component in albizia julibrissin with inhibiting angiogenesis function and preparation method and application thereof |
| 08/13/2008 | CN101239081A Composition for treating cancer and preparation thereof |
| 08/13/2008 | CN101239062A Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 08/13/2008 | CN101239056A Application of NF-kB inhibitor in treating a plurality of diseases |
| 08/13/2008 | CN101239055A Use of Momordica.charantia seed oil riacylglycerol in preparing medicament for inhibiting tumor cell |
| 08/13/2008 | CN101239050A Pentoxifylline sustained release tablets and preparation thereof |
| 08/13/2008 | CN101239043A 5-fluorouracil self-emulsifying nano-scale freeze-dried powder and preparation thereof |
| 08/13/2008 | CN101239040A Celastrol liposome and preparation thereof |
| 08/13/2008 | CN101238876A Health seasoning for pre--cancer-chemotherapy |
| 08/13/2008 | CN101238848A Chinese medicine nucleic acid feed additive |
| 08/13/2008 | CN100410382C Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response |
| 08/13/2008 | CN100410373C siRNA double-chain for suppressing bc1-2 gene expression |
| 08/13/2008 | CN100410275C Novel anti-igf-ir antibodies and uses thereof |
| 08/13/2008 | CN100410274C Specific anti-human liver cancer phage single-chain antibody HscFv4-16 gene and its uses |
| 08/13/2008 | CN100410273C Cancer-suppressing protein and its gene and uses |
| 08/13/2008 | CN100410271C Compound with anti-tumor activity and its preparing method |
| 08/13/2008 | CN100410257C Eremophil dilactone with tumour cell growth inhibiting activity and its use |
| 08/13/2008 | CN100410252C Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100409898C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/13/2008 | CN100409895C Improved antitumoral treatments |
| 08/13/2008 | CN100409855C Tablet containing lucid ganoderma and spirulina spp., and its preparation method |
| 08/13/2008 | CN100409846C Epothilone B liposome formulation and use |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410980 Performing crystallization by using an organic solvent selected from a ketone solvent, a nitrile solvent, and a mixture thereof, or a mixture of organic solvent and water; acetone or acetonitrile can be preferably used as the organic solvent |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/12/2008 | US7410960 Metal complexes and therapeutic uses thereof |
| 08/12/2008 | US7410951 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles |
| 08/12/2008 | US7410946 Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk |
| 08/12/2008 | US7410780 IL-21 antagonists |
| 08/12/2008 | US7410774 Compounds modulating sister chromatid separation and method for identifying same |
| 08/12/2008 | US7410767 Contacting natural killer cells expressing CD94 receptor with human leukocyte antigen (HLA) and test compound; |
| 08/12/2008 | US7410758 Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN |
| 08/12/2008 | US7410656 Isolated euphorbia plant compounds and derivatives; jatrophanes, pepluanes, paralianes, ingenanes; cytotoxicity against malignant melanomas and squamous cell carcinomas |
| 08/12/2008 | US7410655 comprises Potassium tetrachloroplatinate and lignohumic acid ammonium salts; nontoxic |